These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8071609)

  • 1. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Ordovas JM; Cohn SD; Schaefer MM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):871-82. PubMed ID: 8071609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Cohn SD; Schaefer MM; Ordovas JM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):779-92. PubMed ID: 8071601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoprotein and apolipoprotein levels in Taipei and Framingham.
    Lyu LC; Shieh MJ; Ordovas JM; Lichtenstein AH; Wilson PW; Schaefer EJ
    Arterioscler Thromb; 1993 Oct; 13(10):1429-40. PubMed ID: 8399079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
    van Capelleveen JC; Bochem AE; Boekholdt SM; Mora S; Hoogeveen RC; Ballantyne CM; Ridker PM; Sun W; Barter PJ; Tall AR; Zwinderman AH; Kastelein JJP; Wareham NJ; Khaw KT; Hovingh GK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
    Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL and clinical and biochemical correlates in Italian non-smoker women.
    Bigazzi F; Pino BD; Forastiere F; Pistelli R; Rossi G; Simoni M; Baldacci S; Viegi G; Bionda A; Sampietro T
    Clin Chem Lab Med; 2004; 42(12):1408-16. PubMed ID: 15576304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.
    Yamamoto A; Horibe H; Mabuchi H; Kita T; Matsuzawa Y; Saito Y; Nakaya N; Fujioka T; Tenba H; Kawaguchi A; Nakamura H; Goto Y
    Atherosclerosis; 1999 Mar; 143(1):55-73. PubMed ID: 10208480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
    Brinton EA; Eisenberg S; Breslow JL
    Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.
    Wilson PW; Myers RH; Larson MG; Ordovas JM; Wolf PA; Schaefer EJ
    JAMA; 1994 Dec; 272(21):1666-71. PubMed ID: 7966894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
    Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Luc G; Bard JM; Ferrières J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetière P
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1155-61. PubMed ID: 12117731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which fasting triglyceride levels best reflect coronary risk? Evidence from the Turkish Adult Risk Factor Study.
    Onat A; Sansoy V; Yildirim B
    Clin Cardiol; 2001 Jan; 24(1):9-14. PubMed ID: 11195622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
    Montali A; Vega GL; Grundy SM
    Arterioscler Thromb; 1994 Apr; 14(4):511-7. PubMed ID: 8148349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men.
    Abdel-Maksoud MF; Eckel RH; Hamman RF; Hokanson JE
    J Clin Lipidol; 2012; 6(4):374-81. PubMed ID: 22836075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol.
    Le NA; Ginsberg HN
    Metabolism; 1988 Jul; 37(7):614-7. PubMed ID: 3133537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.
    Genest J; McNamara JR; Ordovas JM; Jenner JL; Silberman SR; Anderson KM; Wilson PW; Salem DN; Schaefer EJ
    J Am Coll Cardiol; 1992 Mar; 19(4):792-802. PubMed ID: 1531990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.